Search Results - "Pulmonary circulation"

Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review by Leber, Laurence, Beaudet, Amélie, Muller, Audrey

“…This systematic review of literature and online reports critically appraised incidence and prevalence estimates of pulmonary arterial hypertension and chronic…”
Get full text

Circulating markers of angiogenesis and endotheliopathy in COVID-19 by Pine, Alexander B., Meizlish, Matthew L., Goshua, George, Chang, C-Hong, Zhang, Hanming, Bishai, Jason, Bahel, Parveen, Patel, Amisha, Gbyli, Rana, Kwan, Jennifer M., Won, Christine H., Price, Christina, Dela Cruz, Charles S., Halene, Stephanie, van Dijk, David, Hwa, John, Lee, Alfred I., Chun, Hyung J.

“…Increase in thrombotic and microvascular complications is emerging to be a key feature of patients with critical illness associated with COVID-19 infection…”
Get full text

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI) by Kiely, David G., Levin, David L., Hassoun, Paul M., Ivy, Dunbar, Jone, Pei-Ni, Bwika, Jumaa, Kawut, Steven M., Lordan, Jim, Lungu, Angela, Mazurek, Jeremy A., Moledina, Shahin, Olschewski, Horst, Peacock, Andrew J., Puri, G.D., Rahaghi, Farbod N., Schafer, Michal, Schiebler, Mark, Screaton, Nicholas, Tawhai, Merryn, van Beek, Edwin J.R., Vonk-Noordegraaf, Anton, Vandepool, Rebecca, Wort, Stephen J., Zhao, Lan, Wild, Jim M., Vogel-Claussen, Jens, Swift, Andrew J.

“…Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances…”
Get full text

The cancer theory of pulmonary arterial hypertension by Boucherat, Olivier, Vitry, Geraldine, Trinh, Isabelle, Paulin, Roxane, Provencher, Steeve, Bonnet, Sebastien

“…Pulmonary arterial hypertension (PAH) remains a mysterious killer that, like cancer, is characterized by tremendous complexity. PAH development occurs under…”
Get full text

Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute by Hemnes, Anna R., Kiely, David G., Cockrill, Barbara A., Safdar, Zeenat, Wilson, Victoria J., Al Hazmi, Manal, Preston, Ioana R., MacLean, Mandy R., Lahm, Tim

“…Pregnancy outcomes in patients with pulmonary hypertension remain poor despite advanced therapies. Although consensus guidelines recommend against pregnancy in…”
Get full text

Mechanisms regulating endothelial permeability by Sukriti, Sukriti, Tauseef, Mohammad, Yazbeck, Pascal, Mehta, Dolly

“…The endothelial monolayer partitioning underlying tissue from blood components in the vessel wall maintains tissue fluid balance and host defense through…”
Get full text

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series) by Ranchoux, Benoît, Harvey, Lloyd D., Ayon, Ramon J., Babicheva, Aleksandra, Bonnet, Sebastien, Chan, Stephen Y., Yuan, Jason X.-J., Perez, Vinicio de Jesus

“…Endothelial dysfunction is a major player in the development and progression of vascular pathology in pulmonary arterial hypertension (PAH), a disease…”
Get full text

Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension by Saygin, Didem, Tabib, Tracy, Bittar, Humberto E.T., Valenzi, Eleanor, Sembrat, John, Chan, Stephen Y., Rojas, Mauricio, Lafyatis, Robert

“…Despite recent improvements in management of idiopathic pulmonary arterial hypertension, mortality remains high. Understanding the alterations in the…”
Get full text

In the eye of the storm: the right ventricle in COVID-19 by Park, John F., Banerjee, Somanshu, Umar, Soban

“…The corona virus disease of 2019 pandemic caused by the SARS-CoV-2 virus continues to inflict significant morbidity and mortality around the globe. A variety…”
Get full text

Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension by Mair, Kirsty M., Gaw, Rosemary, MacLean, Margaret R.

“…Obesity is a prevalent global public health issue characterized by excess body fat. Adipose tissue is now recognized as an important endocrine organ releasing…”
Get full text

Pulmonary tumor thrombotic microangiopathy: a systematic review by Godbole, Rohit H., Saggar, Rajan, Kamangar, Nader

“…Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal disease process in which pulmonary hypertension (PH) develops in the setting of malignancy. The…”
Get full text

COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series) by Polverino, Francesca, Celli, Bartolome R., Owen, Caroline A.

“…Chronic obstructive pulmonary disease (COPD) is characterized by chronic expiratory airflow obstruction that is not fully reversible. COPD patients develop…”
Get full text

Pulmonary artery aneurysm: a review by Gupta, Mridul, Agrawal, Abhinav, Iakovou, Annamaria, Cohen, Stuart, Shah, Rakesh, Talwar, Arunabh

“…Pulmonary artery aneurysm is a rare but important entity in the spectrum of pulmonary vascular diseases. The etiologies can be varied and patients can present…”
Get full text

A multidisciplinary pulmonary embolism response team (PERT)—experience from a national multicenter consortium by Schultz, Jacob, Giordano, Nicholas, Zheng, Hui, Parry, Blair A., Barnes, Geoffrey D., Heresi, Gustavo A., Jaber, Wissam, Wood, Todd, Todoran, Thomas, Courtney, D. Mark, Naydenov, Soophia, Khandhar, Sameer, Green, Philip, Kabrhel, Christopher

“…Background We provide the first multicenter analysis of patients cared for by eight Pulmonary Embolism Response Teams (PERTs) in the United States (US);…”
Get full text

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic by Ryan, John J., Melendres-Groves, Lana, Zamanian, Roham T., Oudiz, Ronald J., Chakinala, Murali, Rosenzweig, Erika B., Gomberg-Maitland, Mardi

“…The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard…”
Get full text

Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19? by Horn, Evelyn M., Chakinala, Murali, Oudiz, Ronald, Joseloff, Elizabeth, Rosenzweig, Erika B.

Get full text

Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement by Stenmark, Kurt R., Frid, Maria G., Gerasimovskaya, Evgenia, Zhang, Hui, McCarthy, Mary K., Thurman, Joshua M., Morrison, Thomas E.

“…The outbreak of COVID-19 disease, caused by SARS-CoV-2 beta-coronovirus, urges a focused search for the underlying mechanisms and treatment options. The lung…”
Get full text

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020 by Madani, Michael M.

“…Pulmonary endarterectomy is the treatment of choice for patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) as it is potentially…”
Get full text

Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension by Mahmud, Ehtisham, Patel, Mitul, Ang, Lawrence, Poch, David

“…Balloon pulmonary angioplasty (BPA) is an emerging treatment option for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who have…”
Get full text

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS by Hendrickson, Carolyn M., Matthay, Michael A.

“…Experimental models of sepsis in small and large animals and a variety of in vitro preparations have established several basic mechanisms that drive…”
Get full text